Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants
Clinical trial NCT04484337 · COMPLETED
Trial details
- NCT number
- NCT04484337
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2023-05-05
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.